On the public citation graph
Mouse Models Uniformly Featuring Human-like Lesions Harboring Drug-tolerant Mycobacterium tuberculosis
0 signed · 42 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/path.4399openalex-snapshot
The IL ‐13/ IL‐4R α axis is involved in tuberculosis‐associated pathology
inferredcites →https://doi.org/10.1007/s10096-010-1043-7openalex-snapshot
Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents
inferredcites →https://doi.org/10.1016/j.tim.2005.01.005openalex-snapshot
What's good for the host is good for the bug
inferredcites →https://doi.org/10.1016/j.tube.2009.02.002openalex-snapshot
Man and mouse TB: Contradictions and solutions
inferredcites →https://doi.org/10.1016/j.tube.2012.07.003openalex-snapshot
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1016/j.vaccine.2006.05.097openalex-snapshot
Mycobacterium tuberculosis ΔRD1 ΔpanCD: A safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis
inferredcites →https://doi.org/10.1021/acsinfecdis.5b00127openalex-snapshot
Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice
inferredcites →https://doi.org/10.1038/nm.3937openalex-snapshot
The association between sterilizing activity and drug distribution into tuberculosis lesions
inferredcites →https://doi.org/10.1038/nmicrobiol.2017.72openalex-snapshot
Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis
inferredcites →https://doi.org/10.1038/nri3211openalex-snapshot
Revisiting the role of the granuloma in tuberculosis
inferredcites →https://doi.org/10.1038/nrmicro3200openalex-snapshot
The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
inferredcites →https://doi.org/10.1038/s41598-017-09177-2openalex-snapshot
NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans
inferredcites →https://doi.org/10.1056/nejmoa1313865openalex-snapshot
Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
inferredcites →https://doi.org/10.1056/nejmoa1407426openalex-snapshot
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
inferredcites →https://doi.org/10.1056/nejmoa1901814openalex-snapshot
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
inferredcites →https://doi.org/10.1073/pnas.94.10.5243openalex-snapshot
Identification of nitric oxide synthase as a protective locus against tuberculosis
inferredcites →https://doi.org/10.1084/jem.20021186openalex-snapshot
Virulent but not Avirulent Mycobacterium tuberculosis Can Evade the Growth Inhibitory Action of a T Helper 1–dependent, Nitric Oxide Synthase 2–independent Defense in Mice
inferredcites →https://doi.org/10.1093/infdis/jir786openalex-snapshot
Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions
inferredcites →https://doi.org/10.1111/imr.12252openalex-snapshot
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
inferredcites →https://doi.org/10.1111/j.1365-3083.1990.tb02790.xopenalex-snapshot
Secretory Component‐Binding Properties of Normal Serum IgM
inferredcites →https://doi.org/10.1126/science.1106753openalex-snapshot
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1128/aac.00074-08openalex-snapshot
Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
inferredcites →https://doi.org/10.1128/aac.00105-15openalex-snapshot
Evaluation of Moxifloxacin-Containing Regimens in Pathologically Distinct Murine Tuberculosis Models
inferredcites →https://doi.org/10.1128/aac.00217-12openalex-snapshot
Evaluation of a Mouse Model of Necrotic Granuloma Formation Using C3HeB/FeJ Mice for Testing of Drugs against Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1128/aac.01370-15openalex-snapshot
Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum
inferredcites →https://doi.org/10.1128/aac.02637-15openalex-snapshot
Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis
inferredcites →https://doi.org/10.1128/aac.05293-11openalex-snapshot
Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis
inferredcites →https://doi.org/10.1128/aac.06125-11openalex-snapshot
Phase II Dose-Ranging Trial of the Early Bactericidal Activity of PA-824
inferredcites →https://doi.org/10.1128/aac.49.6.2294-2301.2005openalex-snapshot
Preclinical Testing of the Nitroimidazopyran PA-824 for Activity against Mycobacterium tuberculosis in a Series of In Vitro and In Vivo Models
inferredcites →https://doi.org/10.1128/iai.01515-07openalex-snapshot
Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
inferredcites →https://doi.org/10.1128/iai.68.12.6879-6882.2000openalex-snapshot
Expression of the Nitric Oxide Synthase 2 Gene Is Not Essential for Early Control ofMycobacterium tuberculosisin the Murine Lung
inferredcites →https://doi.org/10.1128/mbio.01023-16openalex-snapshot
Dual-Reporter Mycobacteriophages (Φ 2 DRMs) Reveal Preexisting Mycobacterium tuberculosis Persistent Cells in Human Sputum
inferredcites →https://doi.org/10.1164/rccm.200310-1380ocopenalex-snapshot
Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis
inferredcites →https://doi.org/10.1164/rccm.200407-885ocopenalex-snapshot
Moxifloxacin-containing Regimens of Reduced Duration Produce a Stable Cure in Murine Tuberculosis
inferredcites →https://doi.org/10.1164/rccm.202101-0032ocopenalex-snapshot
Micro–Computed Tomography Analysis of the Human Tuberculous Lung Reveals Remarkable Heterogeneity in Three-dimensional Granuloma Morphology
inferredcites →https://doi.org/10.1172/jci42796openalex-snapshot
Serine protease activity contributes to control of Mycobacterium tuberculosis in hypoxic lung granulomas in mice
inferredcites →https://doi.org/10.1179/joc.2009.21.2.127openalex-snapshot
Bactericidal Activity of Moxifloxacin on Exponential and Stationary Phase Cultures ofMycobacterium tuberculosis
inferredcites →https://doi.org/10.1242/dmm.019513openalex-snapshot
Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis
inferredcites →https://doi.org/10.1242/dmm.019570openalex-snapshot
Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1517/14656566.2015.1084502openalex-snapshot
The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus
inferredcites →https://doi.org/10.2147/idr.s499816openalex-snapshot
Contezolid Harbored Equivalent Efficacy to Linezolid in Tuberculosis Treatment in a Prospective and Randomized Early Bactericidal Activity Study
inferredcites →https://doi.org/10.4049/jimmunol.1202722openalex-snapshot
IL-10 Inhibits Mature Fibrotic Granuloma Formation during Mycobacterium tuberculosis Infection
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.